2025-12-13 - Analysis Report
Okay, here's a breakdown of the provided data for Tempus AI Inc. (TEM), followed by analysis and a comprehensive summary.

**1. Return Rate Comparison & Company Overview**

*   **TEM Company Overview:** Tempus AI Inc. is focused on precision medicine, leveraging AI to analyze molecular and clinical data to personalize healthcare.
*   **TEM Cumulative Return:** 34.05%
*   **S&P 500 (VOO) Cumulative Return:** 31.60%
*   **Divergence:** 3.2 (Relative Divergence: 38.1)
*   **Analysis of Alpha, Beta, and other indicators:**

    *   **CAGR (34.0%):** Demonstrates strong average annual growth over the period 2023-2025.
    *   **MDD (76.7%):**  A very high Maximum Drawdown suggests significant price volatility and risk.
    *   **Alpha (3.0%):** Indicates outperformance relative to its benchmark (risk-adjusted).
    *   **Beta (0.3):** A low Beta suggests the stock is significantly less volatile than the overall market (S&P 500). This appears inconsistent with the high MDD.
    *   **Cap (B) (12.6):** Implies a market capitalization of $12.6 billion.

**2. Recent Stock Price Fluctuations**

*   **Current Close:** $75.07
*   **Last Market Data:** Price: $70.61, Previous Close: $73.86, Change: -$4.40
*   **5-day SMA:** $76.20
*   **20-day SMA:** $72.89
*   **60-day SMA:** $82.02

**3. Indicator Analysis**

*   **MRI (0.8):**  "Medium Investment" recommended based on market risk.
*   **RSI (62.13):**  Neutral.  Not overbought or oversold.
*   **PPO (1.07):**  Positive.  Indicates the 20-day EMA is above the 60-day EMA.
*   **Hybrid Signal:** "cash_0%_Buy 100% of cash (14 shares - Very Safe - MRI:0.90) Monthly invest 5.0% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)" Suggests a bullish investment strategy according to the algorithm.
*   **Recent Divergence Change:** -6.2 (negative indicates a short-term decline relative to the S&P 500).
*   **Recent Price Change:** The significant negative change (-$4.40) from the previous close suggests a notable downward fluctuation.
*   **Expected Return (%):** NaN (Not Available).

**4. Recent News & Significant Events**

*   **Themes:**  The news headlines suggest:
    *   **Buy/Hold/Sell assessments:**  Conflicting opinions exist regarding the stock's investment potential during a "pivotal transition."
    *   **AI Healthcare Momentum:**  The company is benefiting from the broader trend of AI adoption in healthcare.
    *   **Institutional Investment:** FWL Investment Management LLC acquired shares, which is often a positive signal.
    *   **EBITDA Positivity:** Achieving a positive EBITDA is a significant milestone.
    *   **TAM (Total Addressable Market):** The company has a large potential market to tap into.

**4-2. Analyst Opinions**

*   **Consensus:** "Buy" (~2.14 on a 1-5 scale).
*   **Number of Opinions:** 12
*   **Target Price:** Average: $91.42, High: $105.00, Low: $80.00
*   **Recent Rating Changes:** No specific rating changes are provided.

**5. Comprehensive Analysis**

Tempus AI (TEM) presents a mixed picture.

**Positives:**

*   **Strong Growth:** Demonstrates high average annual growth over the 2023-2025 period, and outperforms the S&P 500 (positive Alpha).
*   **Positive Momentum:** Benefiting from the growth of AI in healthcare.
*   **Institutional Interest:** The acquisition of shares by FWL Investment Management is a positive sign.
*   **Analyst Sentiment:** Overall analyst consensus leans toward "Buy" with a substantial average target price significantly above the current price, suggesting potential upside.
*   **EBITDA Positivity** Achieving a positive EBITDA is a significant milestone
*   **Hybrid signal:** "cash_0%_Buy 100% of cash (14 shares - Very Safe - MRI:0.90)"
*   **PPO:** Positive signal

**Negatives/Risks:**

*   **High Volatility:** The significant MDD (76.7%) highlights the stock's high volatility. This does not match the low beta (0.3).
*   **Recent Downturn:** The recent price decline and negative short-term divergence relative to the S&P 500 (-6.2) indicate potential short-term weakness.
*    **Last Market Data:** Price: $70.61, Previous Close: $73.86, Change: -$4.40
*   **Conflicting Signals:** The Buy/Hold/Sell news headlines reflect uncertainty about the stock's future direction.
*   **Expected Return:** Expected return is unavailable.

**Summary:**

TEM is a growth stock operating in the promising AI healthcare sector, with positive analyst ratings and institutional interest. However, it also carries significant risk due to its high volatility and recent downturn, and with conflicting buy/sell/hold sentiment.
Investors should carefully weigh the growth potential against the risks before investing in TEM. The high MDD warrants caution, and investors should be comfortable with potentially large price swings. A closer look at the underlying causes of the high MDD (specific events or broader market factors) would be beneficial. Monitor analyst ratings and news flow for further insights into the company's "pivotal transition."


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.